Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects | BeOne Medicines

Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects

Beigene Study ID

BGB-3111-104

ClinicalTrials.gov ID

NCT03301181

Study Overview

Sex: All

Age: 18 Years / 65 Years

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years / 65 Years

Accepts Healthy Volunteers? yes

No Study Documents